Rockwell Medical (RMTI) Gains from Investment Securities (2010 - 2026)

Rockwell Medical has reported Gains from Investment Securities for 16 years, with the latest figure at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities changed N/A year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (up 268.89% YoY), and the FY2025 full-year result was $77000.0, up 28.33% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $2.4 million, up from $58000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $2.4 million in Q1 2026, with the low at -$1.9 million in Q4 2024.
• Historically, Gains from Investment Securities has averaged $251066.7 across 5 years, with a median of $138000.0 in 2024.
• Annual changes were most pronounced in 2022 — Gains from Investment Securities surged 15250.0% — and 2023, when it tumbled 1590.0%.
• Rockwell Medical's Gains from Investment Securities stood at $303000.0 in 2022, then plunged by 55.78% to $134000.0 in 2023, then slumped by 1535.82% to -$1.9 million in 2024, then surged by 103.01% to $58000.0 in 2025, then jumped by 4124.14% to $2.4 million in 2026.
• The last three Gains from Investment Securities figures came in at $2.4 million (Q1 2026), $58000.0 (Q4 2025), and $124000.0 (Q3 2025), per Business Quant data.